These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21875235)

  • 1. Some more fundamental problems in clinical research: comment on "Statistical significance testing and clinical trials".
    Hofmann SG
    Psychotherapy (Chic); 2011 Sep; 48(3):223-4; discussion 234-6. PubMed ID: 21875235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solving problems with randomized clinical trials is not enough to improve psychotherapy outcome: comments on Krause.
    Lambert MJ
    Psychotherapy (Chic); 2011 Sep; 48(3):229-30; discussion 234-6. PubMed ID: 21875237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving the relationship between the randomized clinical trial and real-world clinical practice.
    Gottdiener WH
    Psychotherapy (Chic); 2011 Sep; 48(3):231-3; discussion 234-6. PubMed ID: 21875238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statistical significance testing and clinical trials.
    Krause MS
    Psychotherapy (Chic); 2011 Sep; 48(3):217-22. PubMed ID: 21875234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statistical significance testing and clinical effectiveness studies.
    Wise EA
    Psychotherapy (Chic); 2011 Sep; 48(3):225-8; discussion 234-6. PubMed ID: 21875236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introduction to the special section: contextualizing significance testing in clinical trials.
    Thompson-Brenner H
    Psychotherapy (Chic); 2011 Sep; 48(3):215-6. PubMed ID: 21875233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cochrane's risk of bias tool in the context of psychotherapy outcome research.
    Munder T; Barth J
    Psychother Res; 2018 May; 28(3):347-355. PubMed ID: 29224503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The meanings and measurement of clinical significance.
    Kazdin AE
    J Consult Clin Psychol; 1999 Jun; 67(3):332-9. PubMed ID: 10369053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partially nested designs in psychotherapy trials: A review of modeling developments.
    Sterba SK
    Psychother Res; 2017 Jul; 27(4):425-436. PubMed ID: 26686878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized clinical trial: myths around elementary statistical principles.
    Edler L; Kopp-Schneider A
    Onkologie; 2003 Dec; 26(6):551-6. PubMed ID: 14709929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized controlled trials and psychotherapy research.
    Rifkin A
    Am J Psychiatry; 2007 Jan; 164(1):7-8. PubMed ID: 17202535
    [No Abstract]   [Full Text] [Related]  

  • 12. ALS issues in clinical trials. Missing data.
    Thompson JL; Levy G
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():48-51. PubMed ID: 15512872
    [No Abstract]   [Full Text] [Related]  

  • 13. Generated effect modifiers (GEM's) in randomized clinical trials.
    Petkova E; Tarpey T; Su Z; Ogden RT
    Biostatistics; 2017 Jan; 18(1):105-118. PubMed ID: 27465235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penalized regression procedures for variable selection in the potential outcomes framework.
    Ghosh D; Zhu Y; Coffman DL
    Stat Med; 2015 May; 34(10):1645-58. PubMed ID: 25628185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of randomized controlled trials.
    Peduzzi P; Henderson W; Hartigan P; Lavori P
    Epidemiol Rev; 2002; 24(1):26-38. PubMed ID: 12119853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychodynamic psychotherapy outcome for generalized anxiety disorder.
    Milrod B
    Am J Psychiatry; 2009 Aug; 166(8):841-4. PubMed ID: 19651745
    [No Abstract]   [Full Text] [Related]  

  • 17. Statistical trial designs and clinical practice: are they compatible?
    Punt CJ
    Onkologie; 2003 Dec; 26(6):518-9. PubMed ID: 14709922
    [No Abstract]   [Full Text] [Related]  

  • 18. Issues in the design of multisite clinical trials of psychotherapy: VA Cooperative Study No. 494 as an example.
    Schnurr PP; Friedman MJ; Engel CC; Foa EB; Shea MT; Resick PM; James KE; Chow BK
    Contemp Clin Trials; 2005 Dec; 26(6):626-36. PubMed ID: 16236558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global benefit-risk assessment in designing clinical trials and some statistical considerations of the method.
    Pritchett YL; Tamura R
    Pharm Stat; 2008; 7(3):170-8. PubMed ID: 17538942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of sampling in clinical trial design.
    Krause M; Lutz W; Boehnke JR
    Psychother Res; 2011 May; 21(3):243-51. PubMed ID: 21347979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.